Example sentences of "with [noun sg] disease " in BNC.
Next page| No | Sentence |
|---|---|
| 1 | ‘ You have just told me what patients with heart disease may or may not do . |
| 2 | Though cholesterol has a bad reputation , a raised level of cholesterol in the blood being one of the risk factors associated with heart disease , it is actually an essential component of the body . |
| 3 | Following a low-fat , low-salt diet and increasing the daily intake of fibre is a necessary part of life for anyone with heart disease or high blood pressure . |
| 4 | Those dealing with heart disease have looked for such clean-cut results in vain . |
| 5 | These are potentially dangerous side effects for anyone with heart disease , epilepsy , asthma , or indeed anyone in a poor mental or physical condition . |
| 6 | To mention but two known effects , regular walking is associated with a reduced incidence of hip fractures in the elderly and beneficial changes in the concentrations of the type of cholesterol associated with heart disease . |
| 7 | Up to 50 per cent of people with heart disease or cancer could probably have prevented or delayed the onset of their illness if they had eaten a better diet or stopped smoking . |
| 8 | No systematic data are available on the population prevalence of possible echocardiographic criteria for diagnosing hypertrophic cardiomyopathy , but one study has found asymmetric septal hypertrophy in 8% of a general population with heart disease other than hypertrophic cardiomyopathy . |
| 9 | At that time smoking had not been linked with heart disease or even with bronchitis — it was seen as a harmless if foolish habit . |
| 10 | As is now possible with heart disease , perhaps preventive approaches will serve to increase the threshold for the appearance of illness . |
| 11 | Some researchers believe that alcohol , whether consumed in the form of beer , wine or spirits , increases the level of high density lipoproteins ( HDL ) in the bloodstream , which in turn reduces the harmful cholesterol levels associated with heart disease ** . |
| 12 | The controversy surrounding cholesterol is enormous : there are even those who deny its link with heart disease . |
| 13 | Just as a doctor links smoking at 20 with chest disease at 50 , research can indicate to social workers the long-term outcomes of current actions . |
| 14 | Conditions in which there is depletion of its , which are essential for emulsifying fats in the gut , are also characterised by low levels of vitamin E. Examples are people with liver disease , or who have had a large part of the ileum ( ’ lower ’ end of the small intestine ) removed . |
| 15 | Patients with liver disease may be susceptible to infection , particularly when this is secondary to alcohol abuse . |
| 16 | According to OPCS , 77 patients with liver disease were admitted on 113 occasions between 1 January 1987 and 31 December 1989 . |
| 17 | Table II shows the disease aetiologies of those 64 patients with liver disease . |
| 18 | We found that although up to 11 ( 17% ) patients admitted with liver disease to a district general hospital over a three year period might reasonably have been considered for liver transplantation , only three ( 5% ) were actually referred . |
| 19 | The number of case notes assessed may underestimate the actual number of patients with liver disease , since recognition of cases is dependent upon admissions being classified within the OPCS codes searched , and patients misclassified would not be identified . |
| 20 | Faecal bile acid excretion was significantly higher in cystic fibrosis patients without liver disease compared with control subjects ( mean ( SEM ) 21.5 ( 2.4 ) and 7.3 ( 1.2 ) umol/kg/24 hours respectively ; p<0.01 ) and patients with liver disease ( 7.9 ( 1.3 ) umol/kg/24 hours ; p<0.01 ) . |
| 21 | SeHCAT retention in cystic fibrosis patients with liver disease was comparable with control subjects ( 30.0 ( SEM ) 8.3% v 36.8 ( 5.9 ) % ; p=NS ) while SeHCAT retention in cystic fibrosis patients who did not have liver disease was significantly reduced ( 19.9 ( 3.8 ) ; p<0.05 ) . |
| 22 | Faecal fat and faecal bile acid analysis was performed on 17 patients with cystic fibrosis ( five with liver disease ) and wight control subjects . |
| 23 | All patients with liver disease had advanced disease with either fibrosis on liver biopsy examination or clinical or endoscopical evidence of portal hypertension . |
| 24 | Faecal bile acid excretion was significantly higher in cystic fibrosis patients without liver disease compared with control subjects ( 21.5 ( 2.4 ) and 7.3 ( 1.2 ) µmol/kg/24 hours respectively ; p<0.01 ) and patients with liver disease ( 7.9 ( 1.3 ) µmol/kg/24 hours ; p<0.01 ) . |
| 25 | The mean percentage seven day retention of SeHCAT in patients with liver disease was 30.0 ( 8.3 ) % and comparable with that in control subjects ( 36.8 ( 5.9 ) % ; p=NS ) . |
| 26 | In contrast a mean percentage seven day retention in patients without liver disease of 19.9 ( 3.8 ) % was lower ( p<0.05 ) than in control subjects and patients with liver disease although the second did not reach statistical significance ( Table II ) . |
| 27 | SeCHAT retention in the remaining five patients with liver disease was similar to , or greater than , the value in control subjects ( Fig 2 ) . |
| 28 | Sixteen ( 48.5% ) of 33 cystic fibrosis patients had an increased fasting breath hydrogen ( three of five patients with liver disease and 13 of 28 patients without liver disease ; p=NS ) ( Table III ) with eight patients having appreciably raised ( >75 ppm ) values ( range 75–780 ppm ) . |
| 29 | Several findings are inconsistent with the theory that an inhibitory effect of unhydrolysed fat on small intestinal bile acid absorption is a major factor responsible for faecal bile acid losses including : ( 1 ) the absence of a correlation between faecal fat excretion and faecal bile acid loss ; ( 2 ) the normal faecal bile acid losses in patients with liver disease compared with the excessive losses in those without liver disease despite similar faecal fat excretion ; and ( 3 ) the finding that patients with near normal fat excretion continue to lose large amounts of bile acids . |
| 30 | Of particular interest were the findings that the defect was present predominantly in patients without liver disease and that bile acid absorption in patients with liver disease was comparable with control subjects . |